Mycobacterium marseillense lymphadenitis: A newly identified strain in the pediatric population - 02/11/21
Doi : 10.1016/j.idnow.2021.03.008
Dimitra Dimopoulou a, ⁎ 
, Anastasia Dimopoulou b, Fanourios Kontos c, Smaragdi Fessatou a, Konstantinos Proikas d, Eleftherios Agniadis a, Nikolaos Zavras b, Achilleas Attilakos a, Vassiliki Papaevangelou a
, Anastasia Dimopoulou b, Fanourios Kontos c, Smaragdi Fessatou a, Konstantinos Proikas d, Eleftherios Agniadis a, Nikolaos Zavras b, Achilleas Attilakos a, Vassiliki Papaevangelou a a Third department of pediatrics, Attikon University General Hospital, National and Kapodistrian University of Athens, Rimini 1, Chaidari, 12642 Athens, Greece
b Department of pediatric surgery, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece
c Laboratory of microbiology, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece
d Second ENT department, Attikon University General Hospital, National and Kapodistrian University of Athens, Athens, Greece
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 2 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | We report a case of NMT lymphadenitis in a previously healthy 4-year-old girl caused by Mycobacterium marseillense, a newly recognized strain belonging to Mycobacterium avium complex. |
• | To our knowledge, there are sparse data in the literature regarding M. marseillense lymphadenitis in children. Since this is a rare and newly described mycobacterium, little is known about the spectrum of disease associated with infection. |
• | The present case demonstrates that, although rare, this strain should be taken into consideration in children with lymphadenitis due to Mycobacterium. |
• | Additional case reports may broaden our understanding of clinical disease spectrum of these new species of mycobacteria and identify optimal management and treatment of such cases. |
Plan
© 2021
Elsevier Masson SAS. Tous droits réservés.
Vol 51 - N° 8
P. 684-685 - novembre 2021 Retour au numéro
Article précédent
- Access and use of quinacrine (mepacrine) in the treatment of resistant giardiasis
- Clemence Delaye, Felipe Suarez, Claire Aguilar, Corinne Guerin, Rui Batista, Celine Chasport, Andre Paugam, Jeremie Zerbit
- Lower nasopharyngeal viral load in young SARS-CoV-2-positive subjects
- Gian Luca Salvagno, Brandon Michael Henry, Giuseppe Lippi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?